Jacobsen, A V
Lowes, K N
Tanzer, M C
Lucet, I S
Hildebrand, J M
Petrie, E J
van Delft, M F
Liu, Z
Conos, S A
Zhang, J-G
Huang, D C S
Silke, J http://orcid.org/0000-0002-7611-5774
Lessene, G
Murphy, J M
Article History
Received: 10 August 2015
Revised: 30 November 2015
Accepted: 2 December 2015
First Online: 14 January 2016
Competing interests
: JS is a member of the Scientific Advisory Board of TetraLogic Pharmaceuticals. GL and JMM lead a programme funded by Catalyst Therapeutics Pty Ltd and the Walter and Eliza Hall Institute to develop necroptosis inhibitors.